Apimeds Pharmaceuticals US, Inc. (APUS)
4.55
-0.07
(-1.52%)
USD |
NYAM |
Oct 14, 11:41
Apimeds Pharmaceuticals US EPS Diluted (Quarterly) : -11.77 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -11.77 |
| March 31, 2026 | -22.60 |
| December 31, 2025 | -0.9186 |
| September 30, 2025 | -1.416 |
| June 30, 2025 | -2.117 |
| March 31, 2025 | -0.5091 |
| December 31, 2024 | -0.2664 |
| Date | Value |
|---|---|
| September 30, 2024 | -0.262 |
| June 30, 2024 | -0.354 |
| March 31, 2024 | -0.2336 |
| December 31, 2023 | -0.4467 |
| September 30, 2023 | -0.0867 |
| June 30, 2023 | -0.0284 |
| March 31, 2023 | -0.0509 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.17M |
| Total Expenses (Quarterly) | 20.17M |
| Enterprise Value | 13.26M |
| Earnings Yield | -806.8% |
| Normalized Earnings Yield | -414.45 |